Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,666   1.18  Index Moved Down -0.07%
CVS CVS WAG GNC Recycling Emerging Markets Rentals Small Growth 
United States GSPC USD ...  |  Company Directory


Processing
Collecting data for PMC

PharMerica management performance

 
 Companies |  Insiders  | Dashboard  
     

PharMerica

Stock@New York Stock Exchange 
United States USD
     
Use PharMerica Corporation management performance together with your other stock asset holdings to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.  Optimize Portfolio

PharMerica Management Effectiveness

The company has Return on Asset of 5.32 % which means that on every $100 spent on asset it made $5.32 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.35 % implying that it generated $5.35 on every 100 dollars invested.

PharMerica Profit Margins

The company has Net Profit Margin of 1.25 % which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 3.99 % which entails that for every 100 dollars of revenue it generated 0.04 of operating income.

PharMerica Insiders

Gregory Weishar CEO and President and Director
Geoffrey Meyers Independent Chairman of the Board, MBA
Suresh Vishnubhatla Senior Vice President CTO
Mark Lindemoen Senior Vice President - Sales and Client Services
Anthony Hernandez Senior Vice President - Human Resources
David Froesel Interim CFO
Michael Culotta CFO and Executive VP
William Monast Executive VP of Sales and Client Management
Robert McKay Sr. VP of Purchasing and Trade Relations
Berard Tomassetti Chief Accounting Officer and Sr. VP
Thomas Caneris Chief Compliance Officer, Sr. VP, General Counsel and Company Secretary
Frank Collins Independent Director
WRobert Dahl Independent Director, MBA
Thomas Gerrity Independent Director
Marjorie Dorr Independent Director, MBA
Robert Oakley Independent Director, MBA
Patrick LePore Independent Director, MBA
Thomas Mahon Independent Director
Moira Conlon IR Officer

PharMerica Corporation Workforce

PharMerica Corporation is rated below average in number of employees category among related companies. The total workforce of Drug Stores industry is at this time estimated at about 658,616. PharMerica maintains roughly 5,000 in number of employees contributing less than 1% to equities under Drug Stores industry.
Gregory Weishar  CEO
CEO and President and Director
Mr. Gregory S. Weishar is Chief Executive Officer, Director of PharMerica Corporation, since January 14, 2007. He has 20 years experience in the pharmacy services industry. Prior to joining the Company, he was Chief Exec...
Geoffrey Meyers  Chairman
Independent Chairman of the Board
Mr. Geoffrey G. Meyers is an Independent Chairman of the Board of Pharmerica Corporation Mr. Meyers has served as a director since November 17, 2009 and as Chairman of the Board since January 1, 2011. Mr. ...

Tenure Analysis

PharMerica employes about 5000 people. The company is managed by 19 executives with total tenure of roughly 70 years, averanging almost 3.0 years of service per executive having 263.0 employee per reported executive.

Return on PharMerica Manpower

Revenue Per Employee 366 K
Revenue Per Executive 96.3 M
Net Income Per Employee 4.6 K
Net Income Per Executive 1.2 M
Working Capital Per Employee 64.7 K
Working Capital Per Executive 17 M

PharMerica Earnings Per Share

According to company disclosure PharMerica Corporation has Earnings Per Share of 0.77 times. This is much higher than that of Services sector, and significantly higher than that of Drug Stores industry, The Earnings Per Share for all stocks is over 1000% lower than the firm.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium